Pfizer agrees to supply additional COVID-19 vaccines, says Japan's vaccine minister | Inquirer News

Pfizer agrees to supply additional COVID-19 vaccines, says Japan’s vaccine minister

/ 12:38 PM April 18, 2021

Japan's Prime Minister Yoshihide Suga addresses a joint news conference with U.S. President Joe Biden in the Rose Garden at the White House in Washington, U.S., April 16, 2021

FILE PHOTO: Japan’s Prime Minister Yoshihide Suga addresses a joint news conference with U.S. President Joe Biden in the Rose Garden at the White House in Washington, U.S., April 16, 2021. REUTERS/Tom Brenner

TOKYO — Pfizer CEO Albert Bourla has agreed to Japanese Prime Minister Yoshihide Suga’s request to supply additional doses of the COVID-19 vaccine, the vaccine minister of Japan said on Sunday.

“They have agreed on the essentials of the matter,” vaccine tzar Taro Kono said during a live interview on Fuji TV, adding that further details including the shipment schedule will be discussed.

ADVERTISEMENT

Kono did not specify the number of extra doses sought from Pfizer, but said Japan would secure enough supply by the end of September to inoculate all people over 16. The Pfizer/BioNTech vaccine is the only one approved in Japan.

FEATURED STORIES

Suga made the request during a telephone call with Bourla on Saturday, the last day of a three-day visit to Washington.

Japan is seeing a surge of new coronavirus cases in recent weeks, which top health experts say is a fourth wave of the COVID-19 pandemic.

Only 0.9% of the Japanese public had received their first vaccine shot as of Friday, compared with 2.5% in South Korea, and 48% in the United Kingdom.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Japan, United States

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.